Adrenal Insufficiency after Long-term use of Topical Glucocorticoids in Patients with Advanced Cutaneous T-cell Lymphomas: A Case Series
DOI:
https://doi.org/10.2340/actadv.v104.19672Keywords:
cutaneous T-cell lymphoma, topical corticosteroids, adrenal insufficiencyAbstract
Abstract is missing (Short communication)
Downloads
References
Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, et al. S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021. J Dtsch Dermatol Ges 2022; 20: 537-554.
https://doi.org/10.1111/ddg.14706 DOI: https://doi.org/10.1111/ddg.14706
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006; 54: 1-15; quiz 16-18.
https://doi.org/10.1016/j.jaad.2005.01.010 DOI: https://doi.org/10.1016/j.jaad.2005.01.010
Phan K, Smith SD. Topical corticosteroids and risk of diabetes mellitus: systematic review and meta-analysis. J Dermatolog Treat 2021; 32: 345-349.
https://doi.org/10.1080/09546634.2019.1657224 DOI: https://doi.org/10.1080/09546634.2019.1657224
Tempark T, Phatarakijnirund V, Chatproedprai S, Watcharasindhu S, Supornsilchai V, Wananukul S. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. Endocrine 2010; 38: 328-334.
https://doi.org/10.1007/s12020-010-9393-6 DOI: https://doi.org/10.1007/s12020-010-9393-6
Nguyen CV, Bohjanen KA. Skin-directed therapies in cutaneous T-cell lymphoma. Dermatol Clin 2015; 33: 683-696.
https://doi.org/10.1016/j.det.2015.05.004 DOI: https://doi.org/10.1016/j.det.2015.05.004
Bockle BC, Jara D, Nindl W, Aberer W, Sepp NT. Adrenal insufficiency as a result of long-term misuse of topical corticosteroids. Dermatology 2014; 228: 289-293.
https://doi.org/10.1159/000358427 DOI: https://doi.org/10.1159/000358427
Levin C, Maibach HI. Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am J Clin Dermatol 2002; 3: 141-147.
https://doi.org/10.2165/00128071-200203030-00001 DOI: https://doi.org/10.2165/00128071-200203030-00001
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, et al. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet 2017; 390: 555-566.
https://doi.org/10.1016/S0140-6736(17)31266-7 DOI: https://doi.org/10.1016/S0140-6736(17)31266-7
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol 2018; 19: 1192-1204.
https://doi.org/10.1016/S1470-2045(18)30379-6 DOI: https://doi.org/10.1016/S1470-2045(18)30379-6
Gonzalez-Rodriguez E, Rodriguez-Abreu D, Spanish Group for Cancer I-B. Immune checkpoint inhibitors: review and management of endocrine adverse events. Oncologist 2016; 21: 804-816.
https://doi.org/10.1634/theoncologist.2015-0509 DOI: https://doi.org/10.1634/theoncologist.2015-0509
Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019; 133: 1703-1714.
https://doi.org/10.1182/blood-2018-11-881268 DOI: https://doi.org/10.1182/blood-2018-11-881268
Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713-1722.
https://doi.org/10.1182/blood-2007-03-055749 DOI: https://doi.org/10.1182/blood-2007-03-055749
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Valerie Glutsch, Patrick Schummer, Ann-Cathrin Koschker, Matthias Goebeler, Marion Wobser
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
